Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase

被引:39
作者
Vaziri, H
Benchimol, S
机构
[1] Univ Toronto, Ontario Canc Inst Princess Margaret Hosp, Toronto, ON M5G 2M9, Canada
[2] Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA
[3] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada
基金
英国医学研究理事会;
关键词
telomerase; hTERT; telomere; senescence; aging; p53; pRb; TIEL; PARP;
D O I
10.1038/sj.onc.1203016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Telomere shortening may be one of several factors that contribute to the onset of senescence in human cells, The p53 and pRb pathways are involved in the regulation of cell cycle progression from G1 into S phase and inactivation of these pathways leads to extension of life span, Short dysfunctional telomeres may be perceived as damaged DNA and may activate these pathways, leading to prolonged arrest in G1, typical of cells in senescence. Inactivation of the p53 and pRb pathways, however, does not lead to cell immortalization, Cells that overcome senescence and have an extended life span continue to lose telomeric DNA and subsequently enter a second phase of growth arrest termed 'crisis', Forced expression of telomerase in human cells leads to the elongation of telomeres and immortalization, The development of human cancer is frequently associated with the inactivation of the pRb and p53 pathways, attesting to the importance of senescence in restricting the tumor-forming ability of human cells, Cancer cells must also maintain telomere length and, in the majority of cases, this is associated with expression of telomerase activity.
引用
收藏
页码:7676 / 7680
页数:5
相关论文
共 70 条
[1]   Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts [J].
Alcorta, DA ;
Xiong, Y ;
Phelps, D ;
Hannon, G ;
Beach, D ;
Barrett, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :13742-13747
[2]   TELOMERE LENGTH PREDICTS REPLICATIVE CAPACITY OF HUMAN FIBROBLASTS [J].
ALLSOPP, RC ;
VAZIRI, H ;
PATTERSON, C ;
GOLDSTEIN, S ;
YOUNGLAI, EV ;
FUTCHER, AB ;
GREIDER, CW ;
HARLEY, CB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10114-10118
[3]   GENETIC INSTABILITY AS A CONSEQUENCE OF INAPPROPRIATE ENTRY INTO AND PROGRESSION THROUGH S-PHASE [J].
ALMASAN, A ;
LINKE, SP ;
PAULSON, TG ;
HUANG, LC ;
WAHL, GM .
CANCER AND METASTASIS REVIEWS, 1995, 14 (01) :59-73
[4]   INCREASED ACTIVITY OF P53 IN SENESCING FIBROBLASTS [J].
ATADJA, P ;
WONG, H ;
GARKAVTSEV, I ;
VEILLETTE, C ;
RIABOWOL, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) :8348-8352
[5]   Reconstitution of human telomerase activity in vitro [J].
Beattie, TL ;
Zhou, W ;
Robinson, MO ;
Harrington, L .
CURRENT BIOLOGY, 1998, 8 (03) :177-180
[6]  
BISCHOFF FZ, 1990, CANCER RES, V50, P7979
[7]   Telomere shortening and tumor formation by mouse cells lacking telomerase RNA [J].
Blasco, MA ;
Lee, HW ;
Hande, MP ;
Samper, E ;
Lansdorp, PM ;
DePinho, RA ;
Greider, CW .
CELL, 1997, 91 (01) :25-34
[8]   Extension of life-span by introduction of telomerase into normal human cells [J].
Bodnar, AG ;
Ouellette, M ;
Frolkis, M ;
Holt, SE ;
Chiu, CP ;
Morin, GB ;
Harley, CB ;
Shay, JW ;
Lichtsteiner, S ;
Wright, WE .
SCIENCE, 1998, 279 (5349) :349-352
[9]  
BOND JA, 1994, ONCOGENE, V9, P1885
[10]   Bypass of senescence after disruption of p21(CIP1/WAF1) gene in normal diploid human fibroblasts [J].
Brown, JP ;
Wei, WY ;
Sedivy, JM .
SCIENCE, 1997, 277 (5327) :831-834